Second Call for applicants to the Nanomedicine Translation Advisory Board

The Second Call for applicants to the Nanomedicine Translation Advisory Board (TAB) is now open to companies, public and private research entities, and other organisations leading Nanomedicine projects in Europe, which target global clinical needs. Applications are due until the 8th May 2016. Selected projects will be invited to attend the TAB-In Sessions, a series of individual meetings with experts to be held on the 28th June 2016, in Basel (Switzerland).

The TAB offers a free advisory service to fast-track promising projects to the market, based on the high-level experience of seasoned Pharma/Biotech translation experts.

The TAB has already received a total of 23 applications from 10 countries in Europe and EU associated countries. 20 of these projects are being actively supported by the TAB to increase their chances of translation for the benefit of Health worldwide.

The Second Call to the TAB is now open to companies, public and private research entities, and other organisations leading Nanomedicine projects in Europe, which target global clinical needs.

Applications for the Second Call are due until the 8th May 2016. Projects to be selected will be invited to attend the Second TAB-In Sessions, a series of individual meetings with experts to be held on the 28th June 2016, in Basel (Switzerland).

Further details:
Second Call for applicants to the Nanomedicine Translation Advisory Board